Journal Questions Sale Of Diet Pill Meridia
NEW YORK — Editors of a top medical journal call Meridia “another flawed diet pill” and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.
Read more on WJXT Jacksonville

Abbott diet drug study renews calls for U.S. ban
WASHINGTON (Reuters) – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Read more on Reuters

Comments are closed.